Menu

Events & Webinars

Preventing Errors During Sterile Compounding: Taking the Next Steps

 
A midday symposium conducted at the 2017 ASHP Midyear Clinical Meeting and Exhibition

Tuesday, December 5, 2017 - 11:30am-1:00pm ET
Room W104, Level 1 – Orange County Convention Center-West Concourse

 

Register to attend in Orlando
 

Overview

More than 90% of hospitalized patients receive some form of intravenous medications or drug infusion therapy during their stay. Unfortunately, this delivery method is not without risks, and errors involving intravenous medications can result in significant patient harm. ISMP’s symposium will address the multi-factorial risks associated with intravenous medications and the need for adoption of proven technologies and best practices to optimize the safety and reliability of sterile compounding. Speakers will discuss safety strategies for infusion therapy and address specific ways to resolve challenges related to operationalizing technology in a variety of pharmacy settings with differing levels of resources.

Objectives

The target audience for this activity includes pharmacists and pharmacy technicians in health-system settings. At the completion of this symposium, the participant will be able to:

  • Describe the evolution of quality and safety in infusion therapy.
  • Identify the most common unsafe practices and at-risk behaviors related to the preparation and administration of sterile medications that are associated with patient harm.
  • Discuss the implementation of infusion-related technologies (IV workflow systems, barcode verification, gravimetric analysis) designed to support safe practices during sterile compounding.
  • List key factors that should be considered when justifying the acquisition of technology to improve the reliability of sterile compounding.

Agenda

10:45am - Doors open
11:30am-1:00pm - Symposium
 
Space is limited and pre-registration is encouraged. Pre-registration is for planning purposes only and seating will be available on a first-come, first-served basis.

Food and beverages are not provided at Midday Symposia. This ASHP policy considers the varied internal policies of commercial supporters related to the Physician Payments Sunshine Act. You are welcome to bring your lunch to the session.

Topics and Faculty

Introduction and Overview
Allen Vaida, PharmD, FASHP
Executive Vice President, ISMP

Infusion Management: Where Are We in Terms of Safety?
Christina Michalek, BS, FASHP
Medication Safety Specialist, ISMP

Advancing Infusion Safety in the Pharmacy
Amanda McCoy, PharmD, RPh
Clinical Pharmacist, St. Elizabeth Healthcare, Edgewood, KY

Gravimetrics and Justifying Use of Technology in Sterile Compounding
Lindsey Amerine, PharmD, MS, BCPS
Assistant Director, Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC

CE Accreditation

Pharmacists and Pharmacy Technicians

This CE activity is jointly provided by ProCE, Inc. and the Institute for Safe Medication Practices (ISMP). ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-17-412-L05-P/T has been assigned to this knowledge-based live CE activity (initial release date December 5, 2017). This CE activity is approved for 1.5 contact hours (0.15 CEUs) in states that recognize ACPE providers. This CE activity is provided at no cost to participants. Successful completion of the online post-test and evaluation at www.ProCE.com no later than January 5, 2018 is required to receive CE credit. CE credit will be automatically uploaded to NABP/CPE Monitor upon completion of the post-test and evaluation. No partial credit will be given.

Disclosure

It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants any significant financial interest or affiliation with companies that manufacture or market products discussed during their presentation. Conflict of interest disclosures are required of all faculty and shall be provided to all participants at the conference.

Please note: The opinions expressed in this activity should not be construed as those of the CE provider. The information and views presented in this activity are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this activity may include the use of drugs and/or devices for unlabeled indications, which should be considered experimental. Participants are advised to consult manufacturer product information and the professional literature, and use professional judgment in applying the presented information in patient-care activities.

Funding

This symposium is funded through an educational grant from BD.

    

Register to attend in Orlando
 

Institute for Safe Medication Practices (ISMP)
200 Lakeside Drive, Suite 200, Horsham, PA 19044
Phone: (215) 947-7797 www.ismp.org